Disgraced former Seagen CEO tapped to lead MorphImmune less than a year after domestic assault arrest

Former Seagen CEO Clay Siegall, Ph.D., will head up a new biotech spun out of Purdue University, less than a year after he stood down from the Seattle-based biopharma in the wake of an arrest for alleged domestic violence.